Issue 3/2005
Content (10 Articles)
A listing of human tumor antigens recognized by T cells: March 2004 update
Luisa Novellino, Chiara Castelli, Giorgio Parmiani
Phase I/II study of immunotherapy with T-cell peptide epitopes in patients with stage IV melanoma
Peter Hersey, Scott W. Menzies, Brendon Coventry, Tam Nguyen, Margaret Farrelly, Susan Collins, Debbie Hirst, Heather Johnson
Spontaneous T-cell responses against peptides derived from the Taxol resistance–associated gene-3 (TRAG-3) protein in cancer patients
Anders Meier, Sine Reker, Inge Marie Svane, Lars Holten-Andersen, Jürgen C. Becker, Ib Søndergaard, Mads Hald Andersen, Per thor Straten
NK cell activation and tumor infiltration are involved in the antitumor mechanism of Virulizin
Ming Yu Cao, Yoon Lee, Ningping Feng, Hui Li, Caigan Du, Dengshun Miao, Jiarong Li, Vivian Lee, Hongnan Jin, Ming Wang, Xiaoping Gu, Jim A. Wright, Aiping H. Young
Peptide immunisation of HLA-DR–transgenic mice permits the identification of a novel HLA-DRβ1*0101– and HLA-DRβ1*0401–restricted epitope from p53
José Manuel Rojas, Stephanie E. B. McArdle, Roger B. V. Horton, Matthew Bell, Shahid Mian, Geng Li, Selman A. Ali, Robert C. Rees
Phase I study of a MUC1 vaccine composed of different doses of MUC1 peptide with SB-AS2 adjuvant in resected and locally advanced pancreatic cancer
Ramesh K. Ramanathan, Kenneth M. Lee, John McKolanis, Elizabeth Hitbold, Wolfgang Schraut, Arthur J. Moser, Elizabeth Warnick, Theresa Whiteside, Jennifer Osborne, Hyoung Kim, Roger Day, Monica Troetschel, Olivera J. Finn
Preoperative mannan-binding lectin pathway and prognosis in colorectal cancer
Henriette Ytting, Ib Jarle Christensen, Jens Christian Jensenius, Steffen Thiel, Hans Jørgen Nielsen
Rituximab induces different but overlapping sets of genes in human B-lymphoma cell lines
Elena Cittera, Chiara Onofri, Maria D’Apolito, Guillaume Cartron, Giovanni Cazzaniga, Leopoldo Zelante, Paolo Paolucci, Andrea Biondi, Martino Introna, Josée Golay
Bridging the innate and adaptive immune responses against cancer: 95th AACR meeting 2004
Olivera J. Finn
Immunotherapy at the American Association for Cancer Research 95th annual meeting: a personal impression
Barbara-ann Guinn